S. Qin
发表
Hong Lu,
Xiangyang Lin,
Xin Wei,
2020,
Human Immunology.
Highly activated TRAIL+ CD56bright NK cells are associated with the liver damage in HBV-LC patients.
Hong Lu,
Xiangyang Lin,
Xin Wei,
2021,
Immunology letters.
Hong Lu,
Xiangyang Lin,
Xin Wei,
2020,
International Immunopharmacology.
Y. Zhu,
Z. Chi,
Z. Wang,
2014,
Scandinavian journal of immunology.
Hong Lu,
Lianfeng Wu,
Xiangyang Lin,
2020,
Clinical Immunology.
R. Duttagupta,
J. Mellors,
G. Kitsios,
2022,
medRxiv.
Xiao‐he Xiao,
Zhaofang Bai,
S. Qin,
2022,
Frontiers in Pharmacology.
Xiangyang Lin,
S. Qin,
Mo Shen,
2023,
International immunopharmacology.
Zhanfei Li,
S. Qin,
Huiming Tang,
2023,
Frontiers in Immunology.
Xiangyang Lin,
S. Qin,
Hengyue Zhu,
2022,
Immunology letters.
Lijiang Chen,
Xiangyang Lin,
S. Qin,
2021,
International immunopharmacology.
Ling-Yun Chen,
S. Qin,
Liang-peng Dong,
2021,
Neoplasma (Bratislava).
Xiangjun Bai,
Zhanfei Li,
S. Qin,
2023,
Shock.